Long-Term Effects of Dextranomer Endoscopic Injections for the Treatment of Urinary Incontinence: An Update of a Prospective Study of 61 Patients

Endoscopic treatment for pediatric severe sphincteric deficiency with dextranomer implant, a nontoxic, nonimmunogenic, nonmigratory synthetic substance, was effective up to 2 years in half of the patients. Subsequently at up to 7 years of followup a slow decrease in efficacy was observed and treatment remained beneficial in 40% of the patients.